| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |